ZA977668B - Chlorofluorocarbon-free mometasone furoate aerosol formulations. - Google Patents

Chlorofluorocarbon-free mometasone furoate aerosol formulations.

Info

Publication number
ZA977668B
ZA977668B ZA9707668A ZA977668A ZA977668B ZA 977668 B ZA977668 B ZA 977668B ZA 9707668 A ZA9707668 A ZA 9707668A ZA 977668 A ZA977668 A ZA 977668A ZA 977668 B ZA977668 B ZA 977668B
Authority
ZA
South Africa
Prior art keywords
chlorofluorocarbon
free
mometasone furoate
aerosol formulations
furoate aerosol
Prior art date
Application number
ZA9707668A
Other languages
English (en)
Inventor
Julianne Berry
Joel A Sequeira
Imtiaz A Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA977668B publication Critical patent/ZA977668B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
ZA9707668A 1996-08-29 1997-08-26 Chlorofluorocarbon-free mometasone furoate aerosol formulations. ZA977668B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29

Publications (1)

Publication Number Publication Date
ZA977668B true ZA977668B (en) 1998-02-26

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707668A ZA977668B (en) 1996-08-29 1997-08-26 Chlorofluorocarbon-free mometasone furoate aerosol formulations.

Country Status (31)

Country Link
EP (1) EP0927037B1 (no)
JP (1) JP3264496B2 (no)
KR (1) KR100316358B1 (no)
CN (1) CN1162157C (no)
AR (1) AR008309A1 (no)
AT (1) ATE202936T1 (no)
AU (1) AU719079B2 (no)
BR (1) BR9711445A (no)
CA (1) CA2263905C (no)
CO (1) CO4900027A1 (no)
CZ (1) CZ294064B6 (no)
DE (1) DE69705628T2 (no)
DK (1) DK0927037T3 (no)
ES (1) ES2159148T3 (no)
GR (1) GR3036674T3 (no)
HK (1) HK1018206A1 (no)
HU (1) HU227915B1 (no)
ID (1) ID18137A (no)
IL (1) IL128714A (no)
MY (1) MY117377A (no)
NO (1) NO322528B1 (no)
NZ (1) NZ334112A (no)
PE (1) PE100198A1 (no)
PL (1) PL189036B1 (no)
PT (1) PT927037E (no)
SA (1) SA97180339B1 (no)
SK (1) SK282147B6 (no)
TR (1) TR199900379T2 (no)
TW (1) TW475901B (no)
WO (1) WO1998008519A1 (no)
ZA (1) ZA977668B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
DE60311665T2 (de) * 2002-08-23 2007-10-25 Schering Corp. Pharmazeutische zusammensetzungen
DE60336602D1 (de) * 2002-08-27 2011-05-12 Schering Corp Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
KR20100004993A (ko) * 2007-02-09 2010-01-13 쉐링 코포레이션 안정한 약제학적 약물 에어로졸
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US6503482B1 (en) * 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
EP0656207B2 (en) * 1991-06-10 2009-07-22 Schering Corporation Non-chlorofluorocarbon aerosol formulations
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
CZ294064B6 (cs) 2004-09-15
IL128714A0 (en) 2000-01-31
HUP9902675A2 (hu) 2000-01-28
SA97180339B1 (ar) 2006-01-31
NO990956D0 (no) 1999-02-26
ID18137A (id) 1998-03-05
MY117377A (en) 2004-06-30
NO990956L (no) 1999-04-28
PE100198A1 (es) 1999-01-11
DE69705628D1 (de) 2001-08-16
TW475901B (en) 2002-02-11
CN1162157C (zh) 2004-08-18
AU719079B2 (en) 2000-05-04
NZ334112A (en) 2000-07-28
PT927037E (pt) 2001-10-31
DK0927037T3 (da) 2001-09-24
PL331828A1 (en) 1999-08-02
HUP9902675A3 (en) 2000-02-28
IL128714A (en) 2003-05-29
CA2263905C (en) 2002-05-14
HK1018206A1 (en) 1999-12-17
GR3036674T3 (en) 2001-12-31
EP0927037A1 (en) 1999-07-07
JP2000503673A (ja) 2000-03-28
CZ63299A3 (cs) 1999-07-14
AR008309A1 (es) 1999-12-29
TR199900379T2 (xx) 1999-05-21
CN1233960A (zh) 1999-11-03
DE69705628T2 (de) 2002-05-08
ATE202936T1 (de) 2001-07-15
AU4232997A (en) 1998-03-19
KR100316358B1 (ko) 2001-12-12
EP0927037B1 (en) 2001-07-11
BR9711445A (pt) 1999-08-24
KR20000035879A (ko) 2000-06-26
ES2159148T3 (es) 2001-09-16
WO1998008519A1 (en) 1998-03-05
SK25399A3 (en) 1999-12-10
HU227915B1 (en) 2012-05-29
JP3264496B2 (ja) 2002-03-11
PL189036B1 (pl) 2005-06-30
SK282147B6 (sk) 2001-11-06
CA2263905A1 (en) 1998-03-05
CO4900027A1 (es) 2000-03-27
NO322528B1 (no) 2006-10-16

Similar Documents

Publication Publication Date Title
HK1022271A1 (en) Pharmaceutical aerosol composition.
PL343491A1 (en) Pharmaceutical aerosol formulation
ZA200204147B (en) Aerosol composition comprising formoterol.
ZA993338B (en) Pharmaceutical formulations.
IL116460A0 (en) Aerosol drug formulations
HUT77377A (hu) Aeroszol készítmények
GB9612297D0 (en) Medicinal aerosol formulations
ZA974735B (en) Pharmaceutical compositions.
ZA978303B (en) Medicinal aerosol formulations
ZA977104B (en) Pharmaceutical compositions.
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
ZA977668B (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations.
EP0674899A3 (en) Deodorant composition.
HK1022853A1 (en) Pharmaceutical compositions.
EP0684038A3 (en) Deodorising preparations.
HK1040488A1 (en) Pharmaceutical formulations.
ZA972602B (en) Pharmaceutical compositions.
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
ZA994697B (en) Pharmaceutical formulation.
ZA99918B (en) Pharmaceutical formulation.
ZA200005761B (en) Pharmaceutical aerosol formulation.
ZA972387B (en) Pharmaceutical formulations.
GB9600887D0 (en) Aerosol formulations
ZA976795B (en) Pharmaceutical formulation.
ZA9710675B (en) Pharmaceutical formulation.